EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Genetic bases of pheochromocytoma and paraganglioma

Alberto Cascón, Bruna Calsina iD, María Monteagudo, Sara Mellid iD, Alberto Díaz-Talavera, Maria Currás-Freixes, Mercedes Robledo iD

Journal of Molecular Endocrinology · 01.04.2023 · 70 (3)

DOI: 10.1530/jme-22-0167 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Endocrinology, erschienen am 01.04.2023. Verfasst von Alberto Cascón und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain. Hauptthemen laut MEDLINE: Pheochromocytoma, Paraganglioma, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 62-mal zitiert (Crossref) und nennt 87 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The genetics of pheochromocytoma and paraganglioma (PPGL) has become increasingly complex over the last two decades. The list of genes involved in the development of these tumors has grown steadily, and there are currently more than 20 driver genes implicated in either the hereditary or the sporadic nature of the disease. Although genetic diagnosis is achieved in about 75–80% of patients, genetic etiology remains unexplained in a significant percentage of cases. Patients lacking a genetic diagnosis include not only those with apparently sporadic PPGL but also patients with a family history of the disease or with multiple tumors, that meet the criteria to be considered as candidates for carrying germline mutations in yet undiscovered genes. Mutations in known PPGL genes deregulate three main signaling pathways (hypoxia, kinase signaling, and Wnt-signaling pathways), which could be the starting point for the development of personalized treatment for PPGL patients. Furthermore, the integration of results from several genomic high-throughput platforms enables the discovery of regulatory mechanisms that cannot be identified by analyzing each piece of information separately. These strategies are powerful tools for elucidating optimal therapeutic options based on molecular biomarkers in PPGL and represent an important step toward the achievement of precision medicine for patients with metastatic PPGL.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PheochromocytomaParagangliomaAdrenal Gland NeoplasmsHumansMutationWnt Signaling Pathway

Stichwörter der Autor:innen

omicsparagangliomapheochromocytomaprecision medicine

Autor:innen und Institutionen

  • Hereditary Endocrine Cancer Group, Spanish National Cancer Research Centre (CNIO), Madrid, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.

ORCID-Profile: Bruna Calsina, Sara Mellid, Mercedes Robledo

Zitieren

APA

Cascón, A., Calsina, B., Monteagudo, M., Mellid, S., Díaz-Talavera, A., Currás-Freixes, M., & Robledo, M. (2023). Genetic bases of pheochromocytoma and paraganglioma. Journal of Molecular Endocrinology, 70(3). https://doi.org/10.1530/jme-22-0167

Vancouver

Cascón A, Calsina B, Monteagudo M, Mellid S, Díaz-Talavera A, Currás-Freixes M, et al. Genetic bases of pheochromocytoma and paraganglioma. Journal of Molecular Endocrinology. 2023;70(3). doi:10.1530/jme-22-0167

BibTeX
@article{Cascn2023,
  author = {Cascón, Alberto and Calsina, Bruna and Monteagudo, María and Mellid, Sara and Díaz-Talavera, Alberto and Currás-Freixes, Maria and Robledo, Mercedes},
  title = {Genetic bases of pheochromocytoma and paraganglioma},
  journal = {Journal of Molecular Endocrinology},
  year = {2023},
  volume = {70},
  number = {3},
  doi = {10.1530/jme-22-0167}
}
Kostenlos starten →